The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC4XD.L Regulatory News (C4XD)

  • There is currently no data for C4XD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

3 Apr 2017 17:22

RNS Number : 4402B
C4X Discovery Holdings PLC
03 April 2017
 

 

For filings with the FCA include the annex

For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

C4X Discovery Holdings Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

X

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

THE AQUARIUS IV FUND LLP

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

03 April 2017

6. Date on which issuer notified:

03 April 2017

7. Threshold(s) that is/are crossed orreached: vi, vii

11%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

Ordinary Shares

GB00BQQ2RV18

4,864,375

4,864,375

4,864,375

4,864,375

10.66%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

4,864,375

10.66%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

DUNCAN PEYTON

15. Contact telephone number:

07879 408000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLLFFRSIIVIID
Date   Source Headline
14th Mar 20177:00 amRNSProposed Placing to raise up to £7.0 million
9th Feb 20177:00 amRNSChange of Adviser
2nd Feb 20177:00 amRNSGRANT OF OPTIONS AND DIRECTORS DEALING
31st Jan 20171:06 pmRNSResult of AGM
6th Jan 20177:00 amRNSFull year results for the year ended 31 July 2016
19th Dec 20167:00 amRNSNotice of Results
30th Nov 20162:25 pmRNSDirector/PDMR Shareholding
24th Nov 20167:00 amRNSGRANT OF OPTIONS AND DIRECTORS DEALING
22nd Nov 20167:00 amRNSBoard Changes
30th Sep 20167:00 amRNSHolding(s) in Company
28th Sep 201610:41 amRNSHolding(s) in Company
28th Sep 20167:00 amRNSC4X Enters New Collaboration with Evotec
26th Sep 201611:53 amRNSResult of General Meeting
6th Sep 20167:00 amRNSC4X Discovery £5 Million Fundraise
12th Jul 20167:00 amRNSAcquisition of drug-discovery technologies
4th Jul 20167:00 amRNSNew drug targets identified for development
4th May 20167:00 amRNSAppointment of Clive Dix as CEO
28th Apr 20163:58 pmRNSHolding(s) in Company
28th Apr 20163:57 pmRNSHolding(s) in Company
26th Apr 20167:00 amRNSGrant of options
17th Mar 20167:00 amRNSInterim Results
15th Mar 201610:00 amRNSNotice of Interim Results
1st Mar 20167:00 amRNSAcquisition of Genetic Analysis Company
9th Dec 20157:00 amRNSDirector/PDMR Shareholding
8th Dec 20152:43 pmRNSResult of AGM
19th Nov 20157:00 amRNSAppointment of Exec Chairman and departure of CEO
29th Oct 20157:00 amRNSDirector/PDMR Shareholding
28th Oct 20157:00 amRNSPreliminary Results
28th Oct 20157:00 amRNSCollaboration with the SGC
7th Oct 20157:00 amRNSResearch update: IL-17
23rd Sep 20157:00 amRNSResearch update: Breakthrough compounds
3rd Sep 20157:00 amRNSSenior Management and Biology Hires
9th Jun 20152:00 pmRNSGrant of Options
20th May 20157:00 amRNSPre-clinical development of drug candidate
27th Apr 20157:00 amRNSInterim Results
21st Apr 20153:05 pmRNSNotice of Results
10th Apr 20153:10 pmRNSChange of Registered Office
10th Apr 20151:34 pmRNSChange of Registered Office
20th Feb 20154:45 pmRNSHolding(s) in Company
19th Jan 20157:00 amRNSC4X enters into new research agreement with Evotec
18th Dec 20147:00 amRNSC4X Discovery renews collaboration with Evotec AG
24th Oct 20143:37 pmRNSHolding(s) in Company
23rd Oct 20144:38 pmRNSTR-1: Notification of Major Interest in Shares
23rd Oct 20143:00 pmRNSTR-1: Notification of Major Interest in Shares
23rd Oct 20147:00 amRNSFirst Day of Dealings on AIM after £11m Placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.